Search research articles
Contact Us
Filters
Showing results (331-340 of 676) with videos related to
Page
of 68
Sort By:
BMJ Open
|
January 21, 2021
Protocol for a non-randomised feasibility study evaluating a codesigned patient safety guide in primary care
Rebecca L Morris, Kay Gallacher, Mark Hann, et al.
Clinical Advances in Hematology & Oncology : H&O
|
October 15, 2005
Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse
Lance H Leopold, Mark S Berger, Su-Chun Cheng, et al.
Inorganic Chemistry
|
December 7, 2017
Cobalt- and Rhodium-Corrole-Triphenylphosphine Complexes Revisited: The Question of a Noninnocent Corrole
Sumit Ganguly, Diemo Renz, Logan J Giles, et al.
Expert Review of Anticancer Therapy
|
January 28, 2015
Targeted therapy of acute myeloid leukemia
Benedito A Carneiro, Jessica K Altman, Jason B Kaplan, et al.
American Journal of Hematology
|
February 19, 2000
Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: an International Oncology Study Group (IOSG) phase II protocol
F J Giles, N R Wickham, B L Rapoport, et al.
Journal of Cellular and Molecular Medicine
|
November 25, 2010
The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
Kevin R Kelly, Jeffrey Ecsedy, Ernest Medina, et al.
British Journal of Haematology
|
March 11, 2004
Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation
Nada Orsolic, Francis J Giles, Henriette Gourdeau, et al.
Oncology Letters
|
November 9, 2018
Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
Andrey V Ugolkov, Maria Matsangou, Timothy J Taxter, et al.
Leukemia & Lymphoma
|
January 28, 1999
Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia
M Beran, E Estey, S M O'Brien, et al.
AJR. American Journal of Roentgenology
|
December 24, 2009
Clinical utility of PET/CT in lymphoma
Carmel G Cronin, Ronan Swords, Mylene T Truong, et al.
Page
of 68
Search research articles
Search
Showing results (331-340 of 676) with videos related to
Sort By:
Page
of 68
BMJ Open
|
January 21, 2021
Protocol for a non-randomised feasibility study evaluating a codesigned patient safety guide in primary care
Rebecca L Morris, Kay Gallacher, Mark Hann, et al.
Clinical Advances in Hematology & Oncology : H&O
|
October 15, 2005
Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse
Lance H Leopold, Mark S Berger, Su-Chun Cheng, et al.
Inorganic Chemistry
|
December 7, 2017
Cobalt- and Rhodium-Corrole-Triphenylphosphine Complexes Revisited: The Question of a Noninnocent Corrole
Sumit Ganguly, Diemo Renz, Logan J Giles, et al.
Expert Review of Anticancer Therapy
|
January 28, 2015
Targeted therapy of acute myeloid leukemia
Benedito A Carneiro, Jessica K Altman, Jason B Kaplan, et al.
American Journal of Hematology
|
February 19, 2000
Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: an International Oncology Study Group (IOSG) phase II protocol
F J Giles, N R Wickham, B L Rapoport, et al.
Journal of Cellular and Molecular Medicine
|
November 25, 2010
The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
Kevin R Kelly, Jeffrey Ecsedy, Ernest Medina, et al.
British Journal of Haematology
|
March 11, 2004
Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation
Nada Orsolic, Francis J Giles, Henriette Gourdeau, et al.
Oncology Letters
|
November 9, 2018
Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
Andrey V Ugolkov, Maria Matsangou, Timothy J Taxter, et al.
Leukemia & Lymphoma
|
January 28, 1999
Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia
M Beran, E Estey, S M O'Brien, et al.
AJR. American Journal of Roentgenology
|
December 24, 2009
Clinical utility of PET/CT in lymphoma
Carmel G Cronin, Ronan Swords, Mylene T Truong, et al.
Page
of 68